Tucson’s NuvOx wins $300K grant

Tucson-based biotech drug startup NuvOx Pharma has been awarded a grant of nearly $300,000 from the National Cancer Institute to study a targeted contrast agent for breast cancer.

Dr. Evan Unger, a University of Arizona radiology professor and co-founder of NuvOx, is co-principal investigator of the grant along with Dr. Juergen Willmann, professor of radiology and a clinical division chief in the radiology department at Stanford University Medical Center.

Read full article here